- Home
- Equipment
- australasia
- vaccines vaccination
Show results for
Refine by
Vaccines Vaccination Equipment Supplied In Australasia
7 equipment items found
Manufactured by:Autima based inSydney, AUSTRALIA
This allows you to replace the thermostat/controller in a fridge with a controller that can be set remotely. This is predominantly for blood/vaccine ...
Manufactured by:Lipotek based inActon, AUSTRALIA
Lipokel is a self adjuvanting small molecule suitable for the formulation of recombinant protein vaccines. Lipokel is very effective at stimulating TLR2 receptors and can be formulated for nasal delivery of vaccines in powder ...
Manufactured by:Lipotek based inActon, AUSTRALIA
Our proprietary Fg115 molecules are also attached to the liposomes to stimulate the TLR5 receptor. The platform improves vaccine internalisation by dendritic cells and results in increased cross presentation. In vivo this translates in increased T cell and antibody and ...
Manufactured by:Poulten & Graf GmbH based inWertheim, GERMANY
Our range of single-use syringes has not only been extended by the sizes 30 and 50 ml, but also by the new packaging units Bulk and ...
Manufactured by:Sartorius AG based inGoettingen, GERMANY
The Recombumin® product portfolio are the highest quality, animal and human origin-free recombinant human albumins commercially available. Our highly pure, safe and consistent albumins enable you to formulate with ...
Manufactured by:BioDiem Ltd. based inSouth Melbourne, AUSTRALIA
BDM-I: Addressing market need for next-generation antimicrobials. Infectious diseases often dominate the media headlines, including rising antibiotic resistance and fear of “super bugs”. One serious problem facing the global community is that anti-infective treatments that were once effective now cannot be relied upon. There are some strains of infections including tuberculosis, blood ...
Manufactured by:BioDiem Ltd. based inSouth Melbourne, AUSTRALIA
A core technology advantage: Live Attenuated Influenza Virus (LAIV) vaccine. BioDiem’s lead asset is the Live Attenuated Influenza Virus (LAIV) vaccine technology. Our LAIV vaccine licensing business involves out-licensing of the company’s platform technology to vaccine manufacturers for the production of intranasal ...